Silencing miR-21 sensitizes non-small cell lung cancer A549 cells to ionizing radiation through inhibition of PI3K/Akt

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Ma, Yongfu ^a   Xia, Hui ^a   Liu, Yang ^a   Li, Min ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 21; OLIGONUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; MICRORNA; MIRN21 MICRORNA, HUMAN; RNA;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION; IONIZING RADIATION; LUNG NON SMALL CELL CANCER; MTT ASSAY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; SENSITIZATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CARCINOMA, NON-SMALL-CELL LUNG; CELL SURVIVAL; GAMMA RADIATION; GENE SILENCING; GENETICS; HUMAN; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; RADIATION DOSE; RADIATION RESPONSE; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SURVIVAL; GAMMA RAYS; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RADIATION TOLERANCE; RNA, NEOPLASM; SIGNAL TRANSDUCTION;

EID: 84900033846     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/617868     Document Type: Article

References (38)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M. J., Cancer statistics, 2008. CA: Cancer Journal for Clinicians 2008 58 2 71 96 2-s2.0-41349099104 10.3322/CA.2007.0010
2. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2012. CA: Cancer Journal for Clinicians 2012 62 1 10 29 2-s2.0-84855792427 10.3322/caac.20138
3. Fidias P., Novello S., Strategies for prolonged therapy in patients with advanced non-small-cell lung cancer. Journal of Clinical Oncology 2010 28 34 5116 5123 2-s2.0-78650491373 10.1200/JCO.2010.30.7074
4. Fuld A. D., Dragnev K. H., Rigas J. R., Pemetrexed in advanced non-small-cell lung cancer. Expert Opinion on Pharmacotherapy 2010 11 8 1387 1402 2-s2.0-77952119805 10.1517/14656566.2010.482560
5. Whitehurst A. W., Bodemann B. O., Cardenas J., Ferguson D., Girard L., Peyton M., Minna J. D., Michnoff C., Hao W., Roth M. G., Xie X.-J., White M. A., Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007 446 7137 815 819 2-s2.0-34147198467 10.1038/nature05697
6. le Péchoux C., Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. Oncologist 2011 16 5 672 681 2-s2.0-79956276306 10.1634/theoncologist.2010-0150
7. Danesi R., Pasqualetti G., Giovannetti E., Crea F., Altavilla G., Del Tacca M., Rosell R., Pharmacogenomics in non-small-cell lung cancer chemotherapy. Advanced Drug Delivery Reviews 2009 61 5 408 417 2-s2.0-67349279836 10.1016/j.addr.2009.03.001
8. Rödel F., Hoffmann J., Distel L., Herrmann M., Noisternig T., Papadopoulos T., Sauer R., Rödel C., Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Research 2005 65 11 4881 4887 2-s2.0-19644370614 10.1158/0008-5472.CAN-04-3028
9. Lee S., Lim M. J., Kim M. H., An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses. Free Radical Biology & Medicine 2012 53 807 816
10. Provencio M., Sánchez A., Garrido P., Valcárce F., New molecular targeted therapies integrated with radiation therapy in lung cancer. Clinical Lung Cancer 2010 11 2 91 97 2-s2.0-77952511165 10.3816/CLC.2010.n.012
11. Lee R. C., Feinbaum R. L., Ambros V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993 75 5 843 854 2-s2.0-0027751663 10.1016/0092-8674(93)90529-Y
12. Iorio M. V., Croce C. M., MicroRNAs in cancer: small molecules with a huge impact. Journal of Clinical Oncology 2009 27 34 5848 5856 2-s2.0-73349125465 10.1200/JCO.2009.24.0317
13. White N. M. A., Fatoohi E., Metias M., Jung K., Stephan C., Yousef G. M., Metastamirs: a stepping stone towards improved cancer management. Nature Reviews Clinical Oncology 2011 8 2 75 84 2-s2.0-79551602747 10.1038/nrclinonc. 2010.173
14. Farazi T. A., Spitzer J. I., Morozov P., Tuschl T., MiRNAs in human cancer. Journal of Pathology 2011 223 2 102 115 2-s2.0-78650034475 10.1002/path.2806
15. Croce C. M., Causes and consequences of microRNA dysregulation in cancer. Nature Reviews Genetics 2009 10 10 704 714 2-s2.0-70349320158 10.1038/nrg2634
16. Ortholan C., Puissegur M.-P., Ilie M., Barbry P., Mari B., Hofman P., MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Current Medicinal Chemistry 2009 16 9 1047 1061 2-s2.0-65649152994 10.2174/092986709787581833
17. Oh J.-S., Kim J.-J., Byun J.-Y., Kim I.-A., Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-ras. International Journal of Radiation Oncology Biology Physics 2010 76 1 5 8 2-s2.0-72049101611 10.1016/j.ijrobp.2009.08.028
18. Salim H., Akbar N. S., Zong D., miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. British Journal of Cancer 2012 107 1361 1373
19. Yan D., Ng W. L., Zhang X., Wang P., Zhang Z., Mo Y.-Y., Mao H., Hao C., Olson J. J., Curran W. J., Wang Y., Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS ONE 2010 5 7, article e11397 2-s2.0-77958133262 10.1371/journal.pone.0011397
20. Markou A., Sourvinou I., Vorkas P. A., Yousef G. M., Lianidou E., Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung Cancer 2013 81 388 396
21. Li S., Liang Z., Xu L., Zou F., MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Molecular and Cellular Biochemistry 2012 360 1-2 147 158 2-s2.0-83555164788 10.1007/s11010-011-1052-6
22. Yang M., Shen H., Qiu C., High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. European Journal of Cancer 2013 49 604 615
23. Wang X.-C., Du L.-Q., Tian L.-L., Wu H.-L., Jiang X.-Y., Zhang H., Li D.-G., Wang Y.-Y., Wu H.-Y., She Y., Liu Q.-F., Fan F.-Y., Meng A.-M., Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer 2011 72 1 92 99 2-s2.0-79952195451 10.1016/j.lungcan.2010.07.014
24. Lao K., Xu N. L., Yeung V., Chen C., Livak K. J., Straus N. A., Multiplexing RT-PCR for the detection of multiple miRNA species in small samples. Biochemical and Biophysical Research Communications 2006 343 1 85 89 2-s2.0-33645106895 10.1016/j.bbrc.2006.02.106
25. Chen C., Ridzon D. A., Broomer A. J., Zhou Z., Lee D. H., Nguyen J. T., Barbisin M., Xu N. L., Mahuvakar V. R., Andersen M. R., Lao K. Q., Livak K. J., Guegler K. J., Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research 2005 33 20, article e179 2-s2.0-29144470346 10.1093/nar/gni178
26. Griveau A., Bejaud J., Anthiya S., Avril S., Autret D., Garcion E., Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death. International Journal of Pharmaceutics 2013 454 765 774
27. Li Y., Zhao S., Zhen Y., Li Q., Teng L., Asai A., Kawamoto K., A miR-21 inhibitor enhances apoptosis and reduces G2-M accumulation induced by ionizing radiation in human glioblastoma U251 cells. Brain Tumor Pathology 2011 28 3 209 214 2-s2.0-80955180085 10.1007/s10014-011-0037-1
28. Anastasov N., Hofig I., Vasconcellos I. G., Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells. Radiation Oncology 2012 7, article 206
29. Drebber U., Lay M., Wedemeyer I., Vallböhmer D., Bollschweiler E., Brabender J., Mönig S. P., Hölscher A. H., Dienes H. P., Odenthal M., Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. International Journal of Oncology 2011 39 2 409 415 2-s2.0-79959960546 10.3892/ijo.2011.1036
30. Liu Z. L., Wang H., Liu J., Wang Z. X., MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Molecular and Cellular Biochemistry 2013 372 35 45
31. Zhang J.-G., Wang J.-J., Zhao F., Liu Q., Jiang K., Yang G.-H., MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clinica Chimica Acta 2010 411 11-12 846 852 2-s2.0-77956061393
32. Hatley M. E., Patrick D. M., Garcia M. R., Richardson J. A., Bassel-Duby R., van Rooij E., Olson E. N., Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 2010 18 3 282 293 2-s2.0-77956501846 10.1016/j.ccr.2010.08.013
33. Seike M., Goto A., Okano T., Bowman E. D., Schetter A. J., Horikawa I., Mathe E. A., Jen J., Yang P., Sugimura H., Gemma A., Kudoh S., Croce C. M., Harris C. C., MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proceedings of the National Academy of Sciences of the United States of America 2009 106 29 12085 12090 2-s2.0-67749110399 10.1073/pnas.0905234106
34. Qiu W., Leibowitz B., Zhang L., Yu J., Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis. Oncogene 2010 29 11 1622 1632 2-s2.0-77949655884 10.1038/onc.2009.451
35. Lei Y., Li H. X., Jin W. S., The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway. International Journal of Radiation Biology 2013 89 12 1079 1086
36. Kim E. J., Jeong J. H., Bae S., Kang S., Kim C. H., Lim Y. B., mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy. Journal of Cellular Biochemistry 2013 114 1248 1256
37. Jung I. L., Kang H. J., Kim K. C., Kim I. G., PTEN/pAkt/p53 signaling pathway correlates with the radioresponse of non-small cell lung cancer. International Journal of Molecular Medicine 2010 25 4 517 523 2-s2.0-77749289244 10.3892/ijmm-00000372
38. Roy S., Yu Y., Padhye S. B., Sarkar F. H., Majumdar A. P., Difluorinated-curcumin, (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21. PLoS One 2013 8, article e68543